MS sequence maps of mRNA using partial RNase T1
A short digest with bead-bound RNase T1 plus tandem MS covers more than 80% of long mRNA sequences in one run, beating complete T1 maps.
Source
Characterization and Sequence Mapping of Large RNA and mRNA Therapeutics Using Mass Spectrometry
Study at a glance
- Design
- Other — Immobilized partial RNase T1 digestion with IP-RP LC–MS/MS for large RNA/mRNA mapping
- N
- Analytical method on 20–40 μg RNA inputs — no biological cohort N
- Population
- Large RNAs and therapeutic mRNA samples
- Outcome
- Sequence coverage from partial vs complete T1 mapping (>80% from one partial digest)
Structured fields used in claim comparison tables when every cited study has a complete layer.
What they did
Authors digested 20–40 μg RNA with immobilized RNase T1 (2–15 min, 37 or 60 °C), separated oligoribonucleotides by IP-RP LC, identified fragments with high-res MS/MS and automated software, and compared complete vs partial T1 maps including spike mRNA.
What they found
>80% sequence coverage of large RNAs/mRNA therapeutics from a single partial digest, better than conventional complete T1 digestion, with few matches to random control sequences. The same workflow can flag modified mRNA and impurities.
The limits
What it doesn't show
A fully validated GMP QC kit with inter-lab precision is still future work; coverage is not 100%, and complete T1 maps remain complementary.
Key terms
- RNase T1
- Endonuclease that cuts after G; partial digestion leaves longer, more unique fragments.
- Sequence coverage
- Fraction of the RNA sequence explained by identified oligoribonucleotides.
- IP-RP HPLC
- Ion-pair reverse-phase LC of RNA (TEAA/acetonitrile).
- Immobilized enzyme
- RNase T1 on magnetic beads for timed, stoppable partial digest.
- mRNA therapeutic mapping
- Confirming sequence identity/integrity of long synthetic mRNAs such as spike.
Flashcards
Research intelligence for this paper
See its role on concept claims, tensions it is part of, placement history, and related discoveries.
Quiz yourself
Partial T1 + MS coverage is:
Common questions
Coverage from one partial digest?
>80% of large RNAs including spike mRNA.
Why partial not complete T1?
Longer fragments improve unique mapping.
Digest scale?
20–40 μg RNA, 2–15 min.
Detection?
UV 260 nm plus HR tandem MS.
More on Mass spectrometry